American Heart Journal
Volume 143, Issue 5 , Pages 753-759, May 2002

Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes☆

Worcester and Boston, Mass, and Antony, France

From the aCardiovascular Thrombosis Research Center, Division of Cardiology, University of Massachusetts Medical School, the bDivision of Cardiology, Beth Israel Deaconess Medical Center, cBrigham and Women's Hospital, Harvard Medical School, and dAventis Pharma

Received 12 March 2001; accepted 3 October 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Reprint requests: Richard C. Becker, MD, Director, Cardiovascular Thrombosis Research Center, University of Massachusetts Medical School, Worcester, MA 01655.

PII: S0002-8703(02)02296-2

doi:10.1067/mhj.2002.120774

American Heart Journal
Volume 143, Issue 5 , Pages 753-759, May 2002

Article Tools

* Image Usage & Resolution